Skip to main content
Erik Dubberke, MD, Infectious Disease, Saint Louis, MO, Barnes-Jewish Hospital

ErikRDubberkeMD

Infectious Disease Saint Louis, MO

Assistant Professor, Internal Medicine, Washington University School of Medicine

Dr. Dubberke is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Dubberke's full profile

Already have an account?

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumFellowship, Infectious Disease, 2002 - 2004
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1999 - 2002
  • University of Illinois College of Medicine
    University of Illinois College of MedicineClass of 1999

Certifications & Licensure

  • MO State Medical License
    MO State Medical License 2000 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Infectious Disease

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Theriva Biologics Announces Presentation of Data from Cohort 1 of the Phase 1b/2a Clinical Trial of SYN-004 (Ribaxamase) in Allogeneic Hematopoietic Cell Transplant Recipients
    Theriva Biologics Announces Presentation of Data from Cohort 1 of the Phase 1b/2a Clinical Trial of SYN-004 (Ribaxamase) in Allogeneic Hematopoietic Cell Transplant RecipientsApril 13th, 2023
  • Synthetic Biologics Reports Second Quarter 2019 Operational Highlights and Financial Results
    Synthetic Biologics Reports Second Quarter 2019 Operational Highlights and Financial ResultsNovember 4th, 2019
  • Gut Makeup Could Make Diarrhea Less Likely
    Gut Makeup Could Make Diarrhea Less LikelyAugust 16th, 2019
  • Join now to see all

Grant Support

  • C. Difficile Disease In Stem Cell Transplant RecipientsNational Institute Of Allergy And Infectious Diseases2009–2011
  • Validation And Modeling Of A C. Difficile Infection Risk Prediction IndexNational Institute Of Nursing Research2009–2010

Hospital Affiliations